139 related articles for article (PubMed ID: 38622276)
21. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
Li X; Zhou J; Huang K; Tang F; Zhou H; Wang S; Jia Y; Sun H; Ma D; Li S
PLoS One; 2015; 10(4):e0122361. PubMed ID: 25860888
[TBL] [Abstract][Full Text] [Related]
22. Clinical implications of elevated pretreatment carcinoembryonic antigen in patients with advanced squamous cell carcinoma of the uterine cervix.
Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Yang SN; Lin FJ
Tumour Biol; 2008; 29(4):255-61. PubMed ID: 18781097
[TBL] [Abstract][Full Text] [Related]
23. CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma.
Zhang J; Dong D; Wei Q; Ren L
BMC Cancer; 2022 Oct; 22(1):1052. PubMed ID: 36207693
[TBL] [Abstract][Full Text] [Related]
24. The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.
Pan L; Cheng J; Zhou M; Yao Z; Zhang Y
J Cancer Res Clin Oncol; 2012 Feb; 138(2):239-46. PubMed ID: 22102174
[TBL] [Abstract][Full Text] [Related]
25. Predictive value of preoperative serum squamous cell carcinoma antigen level for lymph node metastasis in early-stage cervical squamous cell carcinoma.
Zhu C; Zhang W; Wang X; Jiao L; Chen L; Jiang J
Medicine (Baltimore); 2021 Aug; 100(33):e26960. PubMed ID: 34414964
[TBL] [Abstract][Full Text] [Related]
26. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis.
Xu D; Wang D; Wang S; Tian Y; Long Z; Ren X
Int J Gynecol Cancer; 2017 Nov; 27(9):1935-1942. PubMed ID: 28914639
[TBL] [Abstract][Full Text] [Related]
27. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
[TBL] [Abstract][Full Text] [Related]
28. Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making.
Shi L; Liu Y; Li J; Kou J; Ouyang Y; Chen F; Huang X; Huo L; Huang L; Cao X
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5999-6007. PubMed ID: 36624190
[TBL] [Abstract][Full Text] [Related]
29. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
30. Serum squamous cell carcinoma antigen level and magnetic resonance imaging for the prognosis of locally advanced cervical cancer.
Gu LN; Yu JW; Jiang L; Liu TB; Xu Y
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):668-678. PubMed ID: 38305609
[TBL] [Abstract][Full Text] [Related]
31. Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study.
Wu LL; Liu X; Huang W; Lin P; Long H; Zhang LJ; Ma GW
J Cardiothorac Surg; 2020 May; 15(1):115. PubMed ID: 32456707
[TBL] [Abstract][Full Text] [Related]
32. Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy.
Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Moon SH; Cho KH
Radiat Oncol; 2010 Sep; 5():78. PubMed ID: 20840788
[TBL] [Abstract][Full Text] [Related]
33. The value of multiparametric MRI combined with clinical prognostic parameters in predicting the 5-year survival of stage IIIC1 cervical squamous cell carcinoma.
Qin F; Pang H; Ma J; Xu H; Yu T; Luo Y; Dong Y
Eur J Radiol; 2023 Dec; 169():111181. PubMed ID: 37939604
[TBL] [Abstract][Full Text] [Related]
34. Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer.
Gaarenstroom KN; Bonfrer JM; Kenter GG; Korse CM; Hart AA; Trimbos JB; Helmerhorst TJ
Cancer; 1995 Sep; 76(5):807-13. PubMed ID: 8625184
[TBL] [Abstract][Full Text] [Related]
35. Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
Guo HT; Bi XH; Lei T; Lv X; Yao G; Chen Y; Liu C
BMC Cancer; 2020 May; 20(1):441. PubMed ID: 32429859
[TBL] [Abstract][Full Text] [Related]
36. Study on the preoperative value of serum SCC-Ag in predicting the stromal invasion of cervical squamous cell carcinoma.
Qin L
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9167-9171. PubMed ID: 37184678
[TBL] [Abstract][Full Text] [Related]
37. Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma.
Chen P; Jiao L; Ren F; Wang DB
BMC Cancer; 2020 May; 20(1):423. PubMed ID: 32410650
[TBL] [Abstract][Full Text] [Related]
38. Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy.
Wen YF; Cheng TT; Chen XL; Huang WJ; Peng HH; Zhou TC; Lin XD; Zeng LS
PLoS One; 2018; 13(10):e0204334. PubMed ID: 30303986
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer.
Chen W; Xiu S; Xie X; Guo H; Xu Y; Bai P; Xia X
Radiat Oncol; 2022 Jan; 17(1):6. PubMed ID: 35012582
[TBL] [Abstract][Full Text] [Related]
40. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy.
Ogino I; Nakayama H; Okamoto N; Kitamura T; Inoue T
Int J Gynecol Cancer; 2006; 16(3):1094-100. PubMed ID: 16803491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]